Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Depreciation & Amortization (CF) (2020 - 2026)

PROCEPT BioRobotics has reported Depreciation & Amortization (CF) over the past 7 years, most recently at $1.7 million for Q1 2026.

  • Quarterly Depreciation & Amortization (CF) rose 17.63% to $1.7 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $6.6 million through Mar 2026, up 20.36% year-over-year, with the annual reading at $6.4 million for FY2025, 22.09% up from the prior year.
  • Depreciation & Amortization (CF) was $1.7 million for Q1 2026 at PROCEPT BioRobotics, up from $1.7 million in the prior quarter.
  • Over five years, Depreciation & Amortization (CF) peaked at $1.7 million in Q1 2026 and troughed at $642000.0 in Q2 2023.
  • The 5-year median for Depreciation & Amortization (CF) is $1.3 million (2024), against an average of $1.2 million.
  • Year-over-year, Depreciation & Amortization (CF) fell 17.16% in 2022 and then soared 98.79% in 2023.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $663000.0 in 2022, then soared by 98.79% to $1.3 million in 2023, then grew by 10.24% to $1.5 million in 2024, then increased by 17.62% to $1.7 million in 2025, then grew by 1.52% to $1.7 million in 2026.
  • Per Business Quant, the three most recent readings for PRCT's Depreciation & Amortization (CF) are $1.7 million (Q1 2026), $1.7 million (Q4 2025), and $1.6 million (Q3 2025).